Related Experiment Video

Updated: Jun 8, 2025

Application of Hemostatic Devices in Laparoscopic Hepatectomy
04:23

Application of Hemostatic Devices in Laparoscopic Hepatectomy

Published on: April 19, 2022

2.2K

Endoscopic Hemostasis and Antithrombotic Management

Jamie Bering1, Mashal J Batheja1, Neena S Abraham1

  • 1Division of Gastroenterology and Hepatology, Mayo Clinic in Arizona, 13400 East Shea Boulevard, Scottsdale, AZ 85259, USA.

Gastroenterology Clinics of North America
|November 3, 2024
PubMed

Insights

This review covers managing gastrointestinal bleeding (GIB) in patients taking antithrombotic medications. It details risks, benefits, and endoscopic hemostasis techniques for effective patient care.

Area of Science:

  • Gastroenterology
  • Hematology
  • Internal Medicine

Background:

  • Antithrombotic medications are crucial for preventing thrombotic events.
  • Gastrointestinal bleeding (GIB) is a significant complication in patients using these drugs.
  • Balancing antithrombotic therapy benefits against bleeding risks is essential.

Purpose of the Study:

  • To review current literature on managing GIB in patients on antithrombotic therapy.
  • To discuss risk assessment for both initial and recurrent GIB.
  • To provide an overview of endoscopic hemostasis techniques for GIB.

Main Methods:

  • Literature review of antithrombotic management and GIB.
  • Analysis of risks associated with antithrombotic medications.
  • Review of endoscopic hemostasis techniques.

Main Results:

  • Antithrombotic therapy carries inherent bleeding risks, particularly GIB.
  • Recurrent GIB is a significant concern requiring careful management.
  • Various endoscopic techniques offer effective hemostasis for GIB.

Conclusions:

  • Effective management of GIB in patients on antithrombotics requires a careful risk-benefit assessment.
  • Endoscopic hemostasis techniques are vital for controlling GIB.
  • Further research can optimize antithrombotic strategies and bleeding management.

Keywords:
Antithrombotic medicationsEndoscopic hemostasisGastrointestinal bleedNonvariceal bleedRecurrent gastrointestinal bleeding

More Related Videos

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug07:50

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug

Published on: June 4, 2021

2.7K
A Saline/Bipolar Radiofrequency Energy Device As an Adjunct for Hemostasis in Solid Organ Injury/Trauma04:20

A Saline/Bipolar Radiofrequency Energy Device As an Adjunct for Hemostasis in Solid Organ Injury/Trauma

Published on: July 28, 2020

5.2K

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
624
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
46
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
5.9K
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
74
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
477